Samil Pharmaceutical Co.,Ltd (KRX: 000520)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,450
+110 (0.82%)
Nov 15, 2024, 3:30 PM KST

Samil Pharmaceutical Co.,Ltd Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-1,1551,664-28.29-5,3471,341786.26
Upgrade
Depreciation & Amortization
5,4295,3684,9894,7124,1994,016
Upgrade
Loss (Gain) From Sale of Assets
-36.83-1,702-463.24-365.8427.53-17.68
Upgrade
Loss (Gain) From Sale of Investments
5855857.11---
Upgrade
Loss (Gain) on Equity Investments
-0.43-0.49-0.37---
Upgrade
Provision & Write-off of Bad Debts
-646.94-1,187773.39476.66342.8-306.08
Upgrade
Other Operating Activities
8,7267,7858,5267,1309,1487,575
Upgrade
Change in Accounts Receivable
-2,058-446.53-3,783-1,151-4,912-2,109
Upgrade
Change in Inventory
1,827-7,914-644.11-181.39-2,944551.41
Upgrade
Change in Accounts Payable
-10,6457,2955,131-2,2781,676-122.48
Upgrade
Change in Other Net Operating Assets
13,306298.63-10,354-1,578-1,103216.86
Upgrade
Operating Cash Flow
15,33011,7464,1541,4177,77510,590
Upgrade
Operating Cash Flow Growth
-182.76%193.18%-81.78%-26.59%-
Upgrade
Capital Expenditures
-23,069-24,244-48,481-32,828-17,020-13,891
Upgrade
Sale of Property, Plant & Equipment
450.175,213272.79538.32121.5553.18
Upgrade
Sale (Purchase) of Intangibles
-142.75-91.65-175.67217.13-191.51-428.95
Upgrade
Investment in Securities
-585-58511,262-9,80011,814-4,209
Upgrade
Other Investing Activities
-955-69.611,186-3,436686.11-7,577
Upgrade
Investing Cash Flow
-24,302-19,778-35,936-45,308-4,589-26,052
Upgrade
Short-Term Debt Issued
-7,005377.146,6132,5402,945
Upgrade
Long-Term Debt Issued
-31,90877,47934,99720,00051,644
Upgrade
Total Debt Issued
63,46138,91377,85641,60922,54054,589
Upgrade
Short-Term Debt Repaid
--8,612-30,993-2,980-20,500-22,109
Upgrade
Long-Term Debt Repaid
--14,214-14,279-1,431-480.4-522.69
Upgrade
Total Debt Repaid
-46,289-22,827-45,272-4,412-20,981-22,631
Upgrade
Net Debt Issued (Repaid)
17,17216,08632,58437,1981,55931,958
Upgrade
Issuance of Common Stock
-----0.43
Upgrade
Repurchase of Common Stock
----2,492-1,993-
Upgrade
Dividends Paid
---1,001-938.64-918.89-610.35
Upgrade
Other Financing Activities
-7,042-7,603-1,877-1,893-1,969-2,284
Upgrade
Financing Cash Flow
10,1308,48329,70631,874-3,32329,064
Upgrade
Foreign Exchange Rate Adjustments
-1,134-1,448-12.8111.66-583.99126.69
Upgrade
Miscellaneous Cash Flow Adjustments
-0-----
Upgrade
Net Cash Flow
24.25-997.32-2,089-12,005-721.2413,729
Upgrade
Free Cash Flow
-7,740-12,498-44,327-31,411-9,245-3,300
Upgrade
Free Cash Flow Margin
-3.67%-6.37%-24.67%-23.40%-7.52%-2.73%
Upgrade
Free Cash Flow Per Share
-500.50-866.82-3179.29-2271.39-687.53-245.75
Upgrade
Cash Interest Paid
6,9957,5731,8771,8931,9692,284
Upgrade
Cash Income Tax Paid
1,9051,832-36.652,438263.79170.15
Upgrade
Levered Free Cash Flow
-29,149-27,525-37,685-33,164-13,459-9,807
Upgrade
Unlevered Free Cash Flow
-27,503-25,310-35,020-29,287-10,018-7,368
Upgrade
Change in Net Working Capital
13,63410,380-6,1371,6381,09361.84
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.